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1. Introduction 
The activation of adenylate cyclase as a conse- 
quence of the interaction of catabolic hormones with 
the plasma membrane is a well established concept 
[ 11. The concomitant increase of cyclic AMP, the 
second messenger, mediates some of the metabolic 
responses to these hormones. Recently it has been 
shown that NADH, but not NAD or NADPH, can 
inhibit the adenylate cyclase activity in isolated fat- 
cell plasma membranes [2 ] . In view of evidence that 
plasma membranes contain NADH dehydrogenase 
activity [3] which can be influenced by hormones 
that at similar concentration stimulate adenylate 
cyclase activity [4] we were led to question if changes 
in the redox state in intact cells influence the response 
of these cells to hormone stimulation. 
The aim of the present work therefore, was to study 
the influence of a change in the oxidation-reduction 
state on the hormone-induced cyclic AMP production 
in isolated cells, more specificly hepatocytes. Since 
these cells contain alcohol-dehydrogenase the oxida- 
tion-reduction level of the pyridine-nucleotides of 
the cytosol could not only be manipulated by incuba- 
tion with lactate [5 ] but also with ethanol. 
2. Materials and methods 
2.1. Isolation of rat hepatocytes 
Male rats, weighing 150-180 g and fed a regular 
laboratory diet and water ad libitum, were used 
throughout. Parenchymal liver cells were prepared by 
the enzymatic procedure of Christoffersen and Berg 
North-Holland Publishing Company - Amsterdam 
[6]. After preperfusion with Ca”-free Hank’s solution, 
the liver was removed and perfused with buffer con- 
taining 0.05% collagenase and Ca2+ (4 mmol/l) for 
8-10 min with a flow-rate of 30 ml/min. The cells 
were washed 3 times with buffer containing 0.02 mol/l 
Hepes and 1% BSA. The cell-yield was about 300- 
400 X lo6 cells/liver. Viability of the hepatocytes 
was U-90% as determined by Trypan Blue exclusion. 
2.2. Incubation procedure 
The hepatocytes were suspended in a modified 
Krebs-Ringer bicarbonate buffer supplemented with 
glucose and gassed with 95% O2 + 5% CO2 (pH 7.4). 
The composition of the buffer was as follows: 
118.5 mmol/l NaCl, 4.2 mmol/l KCl, 2.0 mmol/l 
CaC12, 1.2 mmol/l MgS04, 1.2 mmol/l KH2P04, 
24.9 mmol/NaHCOa and 10 mmol/l glucose. Aliquots, 
0.5 ml, of buffer containing 8 X IO6 cells/ml and 
ethanol or lactate added to appropriate concentra- 
tion were preincubated for 45 min, at 37°C with 
constant shaking and under continous aeration with 
95% O2 + 5% C02. Glucagon and 3-isobutyl-1 -methyl- 
xanthine as a phosphodiesterase inhibitor in 0.5 ml 
buffer was then added, giving the final concentrations 
indicated in the Results. The incubation was terminat- 
ed after 2 min by adding 10% ice-cold trichloro- 
acetic acid. 
2.3. Determination of cyclic AMP 
After centrifugation of the trichloroacetic acid 
homogenates at 2000 rev./min for 30 min, the super- 
natants were transferred to glass test tubes and HCl 
was added to final concentration of 0.1 mol/l. The 
samples were extracted 4 times with 2 vol. ether and 
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dried at room temperature. Cyclic AMP was deter- 
mined by the protein-binding assay of Gilman [7] as 
modified by Geisler et al. [8 ] . The separation of free 
and bound radioactivity ( [3H]cAMP) was achieved by .+, 
precipitation with 70% saturated (NH4)2S04 solution 5 
containing 2% CaS04. All the procedures, including 8 
counting, were performed in a single assay tube. $ 
Protein was determined in the precipitates by the I 4 
method of Lowry [9], u 
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3. Results 
The basal content of CAMP in liver cells and its 
incubation medium was about 0.7 pmol/mg liver 
protein or 1 pmol/106 hepatocytes. Addition of 
glucagon in concentrations between 1.4 X lo-” and 
1.4 X low7 mol/l gave after 2 min a dose-dependent 
increase in the cyclic AMP content to a maximum of 
lo-20-times the basal level (fig.1). Preincubation with 
ffect of lactate on the basal and glucagon-stimulated 
cyclic AMP formation in hepatocytes. Rat liver cells 
(4 X lob/tube) were preincubated without and in the presence 
of 0.3, 1 and 3 mmol/l lactate for 45 min at 37°C. Glucagon in 
different concentrations and 3-isobutyl-1-methylxanthine 
(10“ mol/l) were then added for 2 min incubation. 4 X lo6 
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Fig.2. Inhibition of cyclic AMP formation by lactate in hepatocytes incubated without and with increasing concentrations of 
glucagon. The values are the means of two experiments. The cyclic AMP values are plotted on a log scale in % control without 
glucagon and lactate. The conditions were as in the legend to fig. 1. 
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lactate in concentrations 0.3, 1 and 3 mmol/l for 
45 min produced a dose-dependent decrease of both 
the basal and glucagon-stimulated increase in CAMP 
content (fig.l). The percentage decrease was similar 
in both basal and glucagon-stimulated CAMP levels as 
caused by lactate preincubation. In fig.2 are summariz- 
ed the results obtained in 2 experiments. Preincubation 
with 3 mmol/l lactate for 4.5 min reduced the CAMP 
content 70-80% at all glucagon concentrations. 
Different lactate concentrations gave a dose-dependent 
inhibition. 
Preincubation with ethanol also decreased both 
the basal and the glucagon-stimulated increase in 
cyclic AMP levels (fig.3). This inhibition increased 
with increase of alcohol concentrations from 3-6 mol/l. 
With ethanol, however, the percentage inhibition of 
CAMP content varied between experiments. Further- 
more, the inhibition varied with the glucagon concen- 
tration as well. 
4. Discussion 
The basal level of cyclic AMP in the isolated hepa- 
tocytes was similar to that found by others [6,10]. 
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Fig.3. Effect of ethanol on the basal and glucagon-stimulated 
cyclic AMP formation in hepatocytes. The hepatocytes 
(4 X lO’/tube) were preincubated without or with 3 mmol/l 
and 6 mmol/l ethanol for 45 min at 37°C. Glucagon in different 
concentrations and 3-isobutyl-1-methyl-xantbine (lo-’ moljl) 
were then added for. 2 min incubation. 
Addition of glucagon in the presence of phospho- 
diesterase inhibitor gave a rapid and dose-dependent 
increase in cyclic AMP accumulation; the sensitivity 
to glucagon was in accordance with that reported by 
others [6,I 1,121. 
Preincubation with lactate or ethanol decreased 
both the basal and glucagon-stimulated cyclic AMP 
accumulation in isolated rat hepatocytes. This result 
is in accordance with earlier findings, that NADH 
caused an inhibition of hormone-stimulated adenylate 
cyclase activity in isolated plasma membranes [2]. 
The impermeability of intact cells for NADH was 
overcome by adding lactate or ethanol, which cross 
the cell-membrane and increase the NADH/NAD ratio 
in the cytosol [5,13]. The oxidation of ethanol to 
acetaldehyde and then to acetate [ 141 in liver cells, 
catalyzed by alcohol dehydrogenase and acetaldehyde 
dehydrogenase respectively, requires NAD as a hydrogen- 
acceptor and generates NADH. 
It is well established that ethanol in vivo reduces 
hepatic gluconeogenesis and causes hypoglycemia 
[ 131. The effect of ethanol in vivo on gluconeogenesis 
is contrary to the glucagon effect, which at least 
partly is mediated by cyclic AMP. The present finding 
that ethanol decreases cyclic AMP generation offers 
an explanation for the hypoglycemic effect of ethanol. 
There is some controversy about the effects of 
alcohol on cyclic AMP formation. Using high concen- 
trations of alcohol Gorman and Bitensky [ 151 found 
stimulation of adenyl cyclase in both whole liver homo- 
genates and washed particle enzyme whereas Mashiter 
et al. [ 161 only found stimulation in plasma membrane 
preparation but not in homogenates. In contrast to 
this, acute administration of ethanol to rats decreased 
the cyclic AMP level in liver cells [17], and inhibited 
the formation of cyclic AMP from ATP prelabelled 
with [3H] adenine [ 181. 
The inhibitory effect of lactate on cyclic AMP 
accumulation had been shown previously in adipo- 
cytes but the authors had no explanation for this [ 191. 
In contradiction to the present results Jarret et al. 
[20] reported that a high ratio of lactate/pyruvate 
in the incubation medium increased the rate of 
glucagon-induced cyclic AMP formation in hepatocytes. 
This discrepancy can be explained by the facts that no 
equilibration period with lactate/pyruvate preceded 
their incubation and no cyclic AMP phosphodiesterase 
inhibitors were used. 
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In conclusion, the present study indicates that 
changes in the intracellular redox situation influence 
cyclic AMP generation and thereby the metabolic 
response to adenylate cyclase stimulating hormone. 
This is in accordance with the previous finding that 
NADH inhibits adenylate cyclase in liver plasma 
membranes. The mechanism by which an increase 
in NADH/NAD ratio can act on the membrane-bound 
adenylate cyclase is not clear, but some kind of coupl- 
ing may exist between the hormone sensitive plasma 
membrane-bound NADH dehydrogenase and adenylate 
cyclase. 
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